[New management of hepatitis B virus].
Sata
M
M
Kumashiro
R
R
D015075:2-Aminopurine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D000077595:Famciclovir; D005857:Germanium; D006509:Hepatitis B / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use*; D018664:Interleukin-12 / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use*; D009942:Organometallic Compounds / Q000627:therapeutic use; D011422:Propionates; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D013947:Thymosin / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000998:Antiviral Agents; D007155:Immunologic Factors; D009942:Organometallic Compounds; D011422:Propionates; D018894:Reverse Transcriptase Inhibitors; D005857:Germanium; D018664:Interleukin-12; C066750:propagermanium; D019259:Lamivudine; D015075:2-Aminopurine; D013947:Thymosin; D007372:Interferons; D000077595:Famciclovir